Form 4 for ARMP Armata Pharmaceuticals, Inc.
Accepted 2025-07-14 00:00:00 ET · period of report 2025-07-10 · accession 0001104659-25-067746 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-14 | 2025-07-10 | ARMP | Birx Deborah | CEO, Dir | F - Tax | $2.27 | -13.6K | 217.4K | -6% | -$31.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-10 | F | D | 13,637 | $2.27 | 217,377 | D | — | — | (F1) Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units. |